HRID2091867

反应详情

EQUATION

反应方程式

HRID 2091867 的结构方程式

PROCEDURE

实验过程

4-(2-chloro-6-((3-(4,4-difluoropiperidin-1-yl)azetidin-1-yl)methyl)pyrido[3,2-d]pyrimidin-4-yl)morpholine was reacted with 1-(tert-butyldimethylsilyl)-5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole via General Procedure A to produce 24.7 mg of 125 following reverse phase HPLC purification.

WORKUP

后处理

  1. customto produce
  2. custom24.7 mg of 125 following reverse phase HPLC purification